Ascletis Pharma (1672.HK) Q3 2026 Earnings

24AugConfirmed
Q1 2025
Q3 2025
Q1 2026
-0.31
-0.24
-0.17
-0.1

Details

Expected EPS
-0.229187328
Actual EPS
N/A
Surprise EPS
0.23
Surprise Percent
+100%

Description

Ascletis Pharma (1672.HK) will report earnings of for Q3 2026 on August 24, 2026.

0 Comments

Share your thoughts